NCT02334501View on ClinicalTrials.gov

Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

Lansoprazole

DRUG

Neratinib

Trial Locations (1)

85283

Celerion, Tempe

All Listed Sponsors
lead

Puma Biotechnology, Inc.

INDUSTRY

NCT02334501 - Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects | Biotech Hunter | Biotech Hunter